Page last updated: 2024-09-04

dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and Injury, Ischemia-Reperfusion

dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination has been researched along with Injury, Ischemia-Reperfusion in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Costard-Jäckle, A; Cremer, J; Harringer, W; Haverich, A; Hirt, SW; Strüber, M1
Brandt, M; Cremer, J; Harringer, W; Haverich, A; Hirt, SW; Strüber, M1
Cremer, J; Harringer, W; Haverich, A; Hirt, SW; Strüber, M1

Other Studies

3 other study(ies) available for dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and Injury, Ischemia-Reperfusion

ArticleYear
Nebulized synthetic surfactant in reperfusion injury after single lung transplantation.
    The Journal of thoracic and cardiovascular surgery, 1995, Volume: 110, Issue:2

    Topics: Adult; Aerosols; Drug Combinations; Fatty Alcohols; Female; Humans; Lung Diseases; Lung Transplantation; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Radiography; Reperfusion Injury

1995
Therapy for lung failure using nitric oxide inhalation and surfactant replacement.
    The Annals of thoracic surgery, 1996, Volume: 61, Issue:5

    Topics: Adult; Drug Combinations; Fatty Alcohols; Humans; Hypoxia; Lung Transplantation; Male; Nitric Oxide; Phosphorylcholine; Polyethylene Glycols; Postoperative Complications; Pulmonary Surfactants; Reperfusion Injury; Respiratory Insufficiency

1996
Surfactant replacement in reperfusion injury after clinical lung transplantation.
    Intensive care medicine, 1999, Volume: 25, Issue:8

    Topics: Adult; Drug Combinations; Fatty Alcohols; Female; Heart-Lung Transplantation; Humans; Lung; Lung Transplantation; Male; Middle Aged; Phosphorylcholine; Polyethylene Glycols; Postoperative Period; Pulmonary Surfactants; Reperfusion Injury; Surface-Active Agents; Treatment Outcome

1999